Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice With Underlying Chronic Granulomatous Disease

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00524-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Combination Therapy With Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Burkholderia Glumae Infection in an Infant With Chronic Granulomatous Disease

Journal of Clinical Microbiology
Microbiology
2006English

Cost-Effectiveness Analysis of Isavuconazole Versus Voriconazole for the Treatment of Patients With Possible Invasive Aspergillosis in Sweden

BMC Infectious Diseases
Infectious Diseases
2019English

Pin68 - Cost-Effectiveness Analysis of Isavuconazole for the Treatment of Invasive Aspergillosis in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pin59 - Estimating the Cost-Effectiveness of Isavuconazole for the Treatment of Patients With Possible Invasive Aspergillosis in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Relapsing Salmonella Enteritidis Infection in a Young Adult Male With Chronic Granulomatous Disease.

Postgraduate Medical Journal
Medicine
1991English

Pin18 - Estimating the Budget and Clinical Impact of Introducing Isavuconazole for the Treatment of Patients With Possible Invasive Aspergillosis in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Chronic Granulomatous Disease

New England Journal of Medicine
Medicine
1972English

Chronic Granulomatous Disease

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy